

(Alliance News) - AbbVie Inc and AstraZeneca PLC on Friday hailed a regulatory win for their joint cancer treatment programme.


(Sharecast News) - AstraZeneca said on Friday that the US Food and Drug Administration has approved its 'Calquence', or acalabrutinib, in combination ...


(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:


(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:


(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings out...


(Alliance News) - Stock prices in London were modestly lower at midday on Friday, with sentiment cautious ahead of US inflation data and the Munich Se...


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:


(Alliance News) - Astrazeneca on Friday hailed positive results from a phase-three trial of its asthma treatment breztri aerosphere.